d Unmet Need Survey.Acta Derm Venereol. 2022;7:102:adv00830. doi: 10.2340/actadv.v102.3932

Chugai Pharmaceutical Co., Ltd. Maruho Obtained Regulatory Approval for Mitchga, the first Antibody Targeting IL-31 for Itching Associated with Atopic Dermatitis. Availableonline. Accessed December 2025

Chugai Pharmaceutical Co., Ltd. Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials. Availableonline. Accessed December 2025

Silverberg J, et al. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 & 2): results from two replicate double-blinded, randomised controlled phase 3 trials.Lancet. 2024;404(10451):445-460. doi: 10.1016/S0140-6736(24)01203-0

Ständer S. Atopic dermatitis.N Engl J Med. 2021;384(12):1136-1143. doi:10.1056/NEJMra2023911

Raharja A, et al. Psoriasis: a brief overview.C
=*=*=*=*=*=
当前为第13/16页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页